Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin effects in patients with myocardial infarction
IRCT20111206008307N44Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dapagliflozin in myocardial infarction (MI), sponsored by Tabriz University of Medical Sciences. Started Jun 2023; status: completed.
02
Drugs
dapagliflozin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20111206008307N44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111206008307N44.